Financial plays

Nestlé's Pure Life range was a star performer for Nestlé Waters

Nestlé first half results: Pros and cons

By Rod Addy

Europe and North America were the worst performing regions for Nestlé according to its first half (H1) results, while Asia, Oceania, Africa and emerging markets delivered double digit growth.

Naturex targets acquisitions as profits rise

Naturex targets acquisitions as profits rise

By Shane Starling

French botanicals supplier has seen profits rise 28% to €9.7m in the first half of 2011 compared to H1 2010, and says its policy of seeking acquisitions remains unchanged.

Dairy prices to soften, says Glanbia

Dairy prices to soften, says Glanbia

By Helen Glaberson

A modest weakening in dairy prices is expected, forecast Glanbia, as the company posted a profit jump in its half year results.

Frutarom profits dip as raw material costs rise

Frutarom profits dip as raw material costs rise

By Shane Starling

Israel-based flavours, botanicals and speciality ingredients player Frutarom has reported lower profits in Q2, with raw material hikes cited as the principal cause.

Profits are up 6.1% at Kerry for H1,

Kerry delivers “solid” H1 with 6% profit hike to €214m

By Shane Starling

Irish dairy and ingredients group Kerry has turned in a”solid” first half of 2011 that saw it increase volumes, weather raw material price hikes, and see success in a “go-to-market” functional ingredient strategy as profits jumped 6.1% on 2010 figures.

DSM on Vitatene, Martek and its investment “shortlist”

Disptaches from Vitafoods Europe 2011

DSM on Vitatene, Martek and its investment “shortlist”

By Shane Starling

DSM’s head of global marketing in human nutrition and health, Gareth Barker, explains why it has bought a carotenoid supplier (approval permitting), how the Martek acquisition is progressing, and why the company is not finished spending yet.

DuPont succeeds in Danisco bid

DuPont succeeds in Danisco bid

By Caroline Scott-Thomas

US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.

DSM reports successful tender offer for Martek

DSM reports successful tender offer for Martek

By Mike Stones

Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...

A solid balance sheet will permit further acquisition activity, Raisio says

Raisio turns in healthy results and promises further acquisitions

By Shane Starling

Finnish ingredients and branded foods player Raisio – the owner of the stanol-cholesterol reduction brand Benecol, will continue seeking acquisitions, it announced in its 2010 financial statement that saw EBIT come in at €19.4m for the year.

It would appear pharma giant Pfizer has gargantuan supplement ambitions as it buys Danish player, Ferrosan

Pfizer acquires Danish food supplements operation

By Shane Starling

Pfizer has acquired the consumer healthcare business of Danish firm Ferrosan for an undisclosed fee in what the pharma giant says, “is an excellent strategic fit that strengthens our presence in dietary supplements”.

Analysts: DuPont Danisco buy-out may end in fire sale

Analysts: DuPont Danisco buy-out may end in fire sale

By Shane Starling

Analysts are saying Danisco could be carved up by its new owner DuPont, which they suggest is most interested in the Danish company’s enzymes for biofuels and that the food side of the business may be jettisoned.

Lactalis pays €8.28m for stake in Spanish ingredients researcher

Lactalis pays €8.28m for stake in Spanish ingredients researcher

By Shane Starling

The Spanish subsidiary of French dairy giant Lactalis has paid €8.28m for 29.9 per cent of the ingredients research division of Spanish dairy group Ebro Foods, which produces the omega-3 forms for Ebro Puleva’s successful €100m+ selling omega-3 milk.

DSM's €24/share offer for Martek remains open until February 21, 2010

DSM’s Greenback formalises €829m Martek tender

By Shane Starling

Greenback Acquisition Corporation, a wholly-owned Royal DSM subsidiary, has begun the formal tender for Martek Biosciences, which DSM announced it was buying for €829m ($1.087bn) last month.

UK stock market regulation crucial to food prices, say economists

UK stock market regulation crucial to food prices, say economists

By Jess Halliday in London

Regulating food speculation in the City of London is the lynchpin to preventing volatility over food prices, say economists, as parallel measures on both sides of the Atlantic will block traders conducting secretive deals wherever they can.

Follow us

Products

View more

Webinars